share_log

Biomarin Pharmaceutical | 8-K: BioMarin Announces Strong Third Quarter 2023 Results, Including Continued Profitability, and 15% Total Revenue Growth Year Over Year

拜玛林制药 | 8-K:BioMarin宣布2023年第三季度强劲业绩,包括持续盈利,总收入同比增长15%

SEC announcement ·  2023/11/01 16:09
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息